| Value | ₹21.90 Cr |
|---|
BSE filing, BSE: 542934. Summary written from the filing by ALFA Finder's alert engine.
Chandra Bhagat Pharma Ltd: key numbers
- Share price
- ₹47.18
- Market cap
- ₹35.60 Cr
- Revenue (annual)
- ₹116.3 Cr
- Net profit (annual)
- ₹3.05 Cr
- P/E (TTM)
- 11.7×Sector 46.5×
- Promoter holding
- 73.02%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Chandra Bhagat Pharma Ltd
All →Chandra Bhagat Pharma Convertible Warrants
Chandra Bhagat Pharma allotted 66 lakh convertible warrants at Rs.44 each, raising Rs.7.26 Crore from 9 allottees. Warrants are convertible 1:1 into equity shares within 18 months.
- Value
- ₹7.26 Cr
Chandra Bhagat Pharma Other Announcement
Chandra Bhagat Pharma Ltd filed a certificate for non-applicability of corporate governance requirements for the September 2026 quarter. This exemption applies to SME-listed entities.
Chandra Bhagat Pharma Preferential Issue
Chandra Bhagat Pharma received BSE in-principle approval for a preferential issue of 66,00,000 warrants at Rs. 44 each. Total issue value is approximately Rs. 2.90 Crore.
- Value
- ₹2.90 Cr
Chandra Bhagat Pharma Management Change
Ms. Rajani Dawani has resigned from her position as Company Secretary and Compliance Officer of Chandra Bhagat Pharma Limited, effective September 30, 2026.
Chandra Bhagat Pharma Annual General Meeting
Chandra Bhagat Pharma Limited conducted its 23rd Annual General Meeting on September 1, 2026, covering annual accounts, director reappointment, capital increase, and warrant issuance.
Chandra Bhagat Pharma Annual General Meeting
Chandra Bhagat Pharma Limited issued a corrigendum to its AGM notice regarding a proposed preferential issue. The update provides a web link to the required compliance certificate.
Other convertible warrants announcements
All →Manaksia Coated Metals & Industries Convertible Warrants
Manaksia's monitoring report shows 20 lakh preferential warrants forfeited for unpaid balance, cutting the issue by Rs 9.75 crore. Objects are unfunded for the reduced amount.
- Value
- ₹9.75 Cr
Unifinz Capital India Convertible Warrants
Unifinz's EGM corrigendum seeks approval for up to 98.01 lakh warrants at ₹102 each, worth ₹99.97 Crore. Vikas Goyal's 11.33 lakh warrants are reallocated to Atika Goyal.
- Value
- ₹99.97 Cr
Avalon Technologies Convertible Warrants
Avalon Technologies issued an EGM notice for 21-Nov-2026 to approve convertible warrants via private placement and a related AoA alteration. No monetary value is disclosed in the notice.
Abhinav Leasing & Finance Convertible Warrants
Abhinav Leasing received BSE in-principle approval to issue 6 crore convertible warrants to non-promoters at ₹164 each, raising ₹984 Crore on preferential basis.
- Value
- ₹984.0 Cr
Taylormade Renewables Convertible Warrants
Taylormade Renewables called an EGM on November 18, 2026 to approve issuing up to 14,00,000 warrants to promoters at ₹71.30 each. The issue aggregates about ₹9.98 Crore.
- Value
- ₹9.98 Cr
Embassy Developments Convertible Warrants
Embassy Developments' promoter group entity converted 2.32 crore warrants into equity at INR 111.51 each. The conversion is valued at INR 258.70 crore.
- Value
- ₹258.7 Cr